EP Europace
Covering the fields of arrhythmias, pacing and cellular electrophysiology
Showing 24 of 7789 results
ESC Journals
Response to the letter regarding ‘Outcomes of functional ventricular tachycardia ablation vs. medical therapy in Chagas cardiomyopathy patients with implantable cardioverter-defibrillators: a competing risks analysis’
18 September 2026
ESC Journals
Amiodarone dose to treat ventricular tachycardia in Chagas cardiomyopathy
18 September 2026
ESC Journals
The second beat matters: coupling intervals and sudden cardiac death risk in hypertrophic cardiomyopathy
17 September 2026
ESC Journals
Associations between specific non-sustained ventricular tachycardia characteristics and sudden cardiac death in hypertrophic cardiomyopathy
17 September 2026
ESC Journals
The latest Fontan paradox: when less is more (difficult)
14 September 2026
ESC Journals
Late arrhythmias following Fontan completion: insights from a Korean Multicentre Fontan Registry of over 1000 extracardiac conduit surgeries
14 September 2026
ESC Journals
Colchicine initiated before radiofrequency-induced injury attenuates left atrial inflammation, fibrosis, and susceptibility to atrial fibrillation
11 September 2026
ESC Journals
COnCOmitaNt pulsed field ablation-based pUlmonary vein isolation and lefT atrial appendage closure: the COCONUT study
9 September 2026
ESC Journals
Programmed ventricular stimulation for risk stratification in symptomatic athletes with nonischemic left ventricular scar and preserved ejection fraction
8 September 2026
ESC Journals
Sex-associated differences in lesion delivery and atrial fibrillation recurrence after cryoballoon ablation
4 September 2026
ESC Journals
Minimized atrial pacing and atrial fibrillation burden in the DANPACE II trial
4 September 2026
ESC Journals
Selective activation of tetrodotoxin-sensitive sodium channels by AaH-II drives arrhythmogenic late Na<sup>+</sup> current in the heart
3 September 2026
ESC Journals
Pulsed-field ablation for atrial fibrillation with an extended protocol: the extended PFA dose study
3 September 2026
ESC Journals
Pulmonary vein isolation durability in a randomized trial comparing fluoroscopy-only vs. electroanatomic mapping strategies for pulmonary vein isolation with balloon-in-basket pulsed-field ablation
3 September 2026
ESC Journals
Prognostic value of isolated PR interval prolongation after transcatheter aortic valve implantation
3 September 2026
ESC Journals
Percutaneous left stellate ganglion block for drug-refractory supraventricular arrhythmias in patients with advanced heart failure and cardiogenic shock: a pilot study
3 September 2026
ESC Journals
Incident heart failure in patients with screening-detected atrial fibrillation: a <em>post hoc</em> analysis of the STROKESTOP and STROKESTOP II studies
3 September 2026
ESC Journals
Incidence and clinical implications of ventricular tachycardia: a population-based approach
3 September 2026
ESC Journals
Impaired sinus rate behaviour during ventricular arrhythmia is associated with adverse outcomes in implantable cardioverter-defibrillator recipients
3 September 2026
ESC Journals
Identifying patients at low risk for atrial fibrillation after cryptogenic stroke: the PAVA score
3 September 2026
ESC Journals
Combined unipolar and bipolar voltage mapping for atrial substrate assessment: associations with arrhythmia recurrence after redo ablation
3 September 2026
ESC Journals
Bleeding-related conditions, procedural safety, and mortality after left atrial appendage closure
3 September 2026
ESC Journals
Essential antiarrhythmic drug accessibility worldwide: a multi-survey study and comprehensive evaluation of access and supply challenges
2 September 2026
ESC Journals
Cryoballoon ablation vs. antiarrhythmic drug therapy as initial treatment for persistent atrial fibrillation: <em>the multicentre randomized CEPAF trial</em>
1 September 2026


